Targeting the PD-1/PD-L1 axis in non-small cell lung cancer

Kumar, R; Collins, D; Dolly, S; McDonald, F; O'Brien, MER; Yap, TA

Yap, TA (reprint author), Royal Marsden NHS Fdn Trust, Drug Dev Unit, Downs Rd, London SM2 5PT, England.

CURRENT PROBLEMS IN CANCER, 2017; 41 (2): 111

Abstract

The last decade has witnessed rapid advances in the discovery and development of immune checkpoint inhibitors in cancer medicine, particularly drugs t......

Full Text Link